169 related articles for article (PubMed ID: 35897938)
1. Halogenated Flavonoid Derivatives Display Antiangiogenic Activity.
Khater M; Watson KA; Boateng SY; Greco F; Osborn HMI
Molecules; 2022 Jul; 27(15):. PubMed ID: 35897938
[TBL] [Abstract][Full Text] [Related]
2. Exploring quercetin and luteolin derivatives as antiangiogenic agents.
Ravishankar D; Watson KA; Boateng SY; Green RJ; Greco F; Osborn HM
Eur J Med Chem; 2015 Jun; 97():259-74. PubMed ID: 25984842
[TBL] [Abstract][Full Text] [Related]
3. Effect of hydroxyl substitution of flavone on angiogenesis and free radical scavenging activities: a structure-activity relationship studies using computational tools.
Rajesh G; Harshala S; Dhananjay G; Jadhav A; Vikram G
Eur J Pharm Sci; 2010 Jan; 39(1-3):37-44. PubMed ID: 19874890
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activity.
Elsayed NMY; Serya RAT; Tolba MF; Ahmed M; Barakat K; Abou El Ella DA; Abouzid KAM
Bioorg Chem; 2019 Feb; 82():340-359. PubMed ID: 30428414
[TBL] [Abstract][Full Text] [Related]
5. Epoxyquinol B shows antiangiogenic and antitumor effects by inhibiting VEGFR2, EGFR, FGFR, and PDGFR.
Kamiyama H; Kakeya H; Usui T; Nishikawa K; Shoji M; Hayashi Y; Osada H
Oncol Res; 2008; 17(1):11-21. PubMed ID: 18488711
[TBL] [Abstract][Full Text] [Related]
6. Total Flavones of Abelmoschus manihot Exhibits Pro-Angiogenic Activity by Activating the VEGF-A/VEGFR2-PI3K/Akt Signaling Axis.
Zhu GS; Tang LY; Lv DL; Jiang M
Am J Chin Med; 2018; 46(3):567-583. PubMed ID: 29595071
[TBL] [Abstract][Full Text] [Related]
7. Biphenylurea/thiourea derivatives tagged with heteroarylsulfonamide motifs as novel VEGFR2 inhibitors; Design, synthesis and anti-angiogenic activity.
Al-Ansary GH; Nasr T; Taha H; Fayad W; Mahgoub S
Bioorg Chem; 2021 Feb; 107():104640. PubMed ID: 33485105
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of selected flavonoids as antiangiogenic, anticancer, and radical scavenging agents: an experimental and in silico analysis.
Gacche RN; Shegokar HD; Gond DS; Yang Z; Jadhav AD
Cell Biochem Biophys; 2011 Dec; 61(3):651-63. PubMed ID: 21830125
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity and mode of action of four naturally occuring flavonoids from the genus Dorstenia: gancaonin Q, 4-hydroxylonchocarpin, 6-prenylapigenin, and 6,8-diprenyleriodictyol.
Kuete V; Ngameni B; Wiench B; Krusche B; Horwedel C; Ngadjui BT; Efferth T
Planta Med; 2011 Dec; 77(18):1984-9. PubMed ID: 21800276
[TBL] [Abstract][Full Text] [Related]
10. YLT192, a novel, orally active bioavailable inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Xia Y; Song X; Li D; Ye T; Xu Y; Lin H; Meng N; Li G; Deng S; Zhang S; Liu L; Zhu Y; Zeng J; Lei Q; Pan Y; Wei Y; Zhao Y; Yu L
Sci Rep; 2014 Aug; 4():6031. PubMed ID: 25112436
[TBL] [Abstract][Full Text] [Related]
11. Herbal compound farnesiferol C exerts antiangiogenic and antitumor activity and targets multiple aspects of VEGFR1 (Flt1) or VEGFR2 (Flk1) signaling cascades.
Lee JH; Choi S; Lee Y; Lee HJ; Kim KH; Ahn KS; Bae H; Lee HJ; Lee EO; Ahn KS; Ryu SY; Lü J; Kim SH
Mol Cancer Ther; 2010 Feb; 9(2):389-99. PubMed ID: 20103598
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic activity of xanthomicrol and calycopterin, two polymethoxylated hydroxyflavones in both in vitro and ex vivo models.
Abbaszadeh H; Ebrahimi SA; Akhavan MM
Phytother Res; 2014 Nov; 28(11):1661-70. PubMed ID: 24895220
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic Effect of Isomalyngamide A Riboside CY01 in Breast Cancer Cells
Shih CY; Chang TT; Chen CL; Li WS
Anticancer Agents Med Chem; 2020; 20(3):386-399. PubMed ID: 31629398
[TBL] [Abstract][Full Text] [Related]
14. Oleanolic Acid Inhibits Colorectal Cancer Angiogenesis by Blocking the VEGFR2 Signaling Pathway.
Niu G; Sun L; Pei Y; Wang D
Anticancer Agents Med Chem; 2018; 18(4):583-590. PubMed ID: 29065844
[TBL] [Abstract][Full Text] [Related]
15. Effect of selected flavones on cancer and endothelial cells.
Pilátová M; Stupáková V; Varinská L; Sarisský M; Mirossay L; Mirossay A; Gál P; Kraus V; Dianisková K; Mojzis J
Gen Physiol Biophys; 2010 Jun; 29(2):134-43. PubMed ID: 20577025
[TBL] [Abstract][Full Text] [Related]
16. Quinazoline clubbed 1,3,5-triazine derivatives as VEGFR2 kinase inhibitors: design, synthesis, docking, in vitro cytotoxicity and in ovo antiangiogenic activity.
Pathak P; Shukla PK; Kumar V; Kumar A; Verma A
Inflammopharmacology; 2018 Dec; 26(6):1441-1453. PubMed ID: 29663100
[TBL] [Abstract][Full Text] [Related]
17. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
[TBL] [Abstract][Full Text] [Related]
18. Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2-mediated PI3K/Akt/mTOR signaling pathway.
He L; Wu Y; Lin L; Wang J; Wu Y; Chen Y; Yi Z; Liu M; Pang X
Cancer Sci; 2011 Jan; 102(1):219-25. PubMed ID: 21087351
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic Activity of Flavonoids: A Systematic Review and Meta-Analysis.
Khater M; Greco F; Osborn HMI
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066630
[No Abstract] [Full Text] [Related]
20. Platycodin D inhibits tumor growth by antiangiogenic activity via blocking VEGFR2-mediated signaling pathway.
Luan X; Gao YG; Guan YY; Xu JR; Lu Q; Zhao M; Liu YR; Liu HJ; Fang C; Chen HZ
Toxicol Appl Pharmacol; 2014 Nov; 281(1):118-24. PubMed ID: 25250884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
